{
  "ticker": "IMU",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02969814",
  "id": "02969814",
  "pages": 2,
  "price_sensitive": false,
  "date": "20250716",
  "time": "1245",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250716/pdf/06lvfhpkj7sk5t.pdf",
  "summary": "**Summary of ASX Announcement:**  \n\n- **Webinar Announcement**: Imugene Limited will present **new Phase 1b trial data** for **azer-cel** (CD19-targeting CAR T therapy) via webinar on **17 July 2025 at 11am AEST**.  \n- **No material trading/data points disclosed**\u2014await webinar for clinical updates.  \n\n*Note*: No immediate capital, financial, or operational impacts; focus is on upcoming data presentation.",
  "usage": {
    "prompt_tokens": 949,
    "completion_tokens": 102,
    "total_tokens": 1051,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-07-16T04:53:19.834859"
}